CTLA4/CT60 polymorphism is not relevant in susceptibility to autoimmune inflammatory intestinal disorders
Authors:
- B. RuedaBRB. Rueda
- A. ZhernakovaAZA. Zhernakova
- M.A. López-NevotMLM.A. López-Nevot
- M. Gomez-GarciaMGM. Gomez-Garcia
- E. OrtegaEOE. Ortega
- A. PiñeroAPA. Piñero
- F. CorreroFCF. Correro
- J.A. BrievaJBJ.A. Brieva
- A. NietoANA. Nieto
- B.P.C. KoelemanBKB.P.C. Koeleman
- J. MartínJ. Martín
- 1 March 2005
- journal article
- Published by Elsevier in Human Immunology
- Vol. 66 (3) , 321-325
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairsHuman Molecular Genetics, 2004
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- HLA in coeliac disease: Unravelling the complex genetics of a complex disorderTissue Antigens, 2003
- The genetics of inflammatory bowel diseaseGastroenterology, 2003
- Coeliac disease: dissecting a complex inflammatory disorderNature Reviews Immunology, 2002
- Genome screening of coeliac diseaseJournal of Medical Genetics, 2002
- Haplotype tagging for the identification of common disease genesNature Genetics, 2001
- CTLA-4 in autoimmune diseases – a general susceptibility gene to autoimmunity?Genes & Immunity, 2000
- An Mse I RFLP in the Human CTLA4 PromotorBiochemical and Biophysical Research Communications, 1996
- Mapping of a susceptibility locus for Crohn's disease on chromosome 16Nature, 1996